NerveWave Neuro-Modulating Electrotherapy System

• Using clinically studied electrotherapy specifications derived from the Jstim – Joint Stimulator; low-level frequencies are coupled with high volt stimulation set to a monophasic waveform. Such specifications have been studied to promote cartilage regeneration in the joint.
• Interferential therapy (IFT) targets chronic intractable back pain by using intersecting medium-frequency electrical currents to penetrate deep tissue, block pain signals, reduce inflammation, and improve muscle relaxation. This technique is especially effective for pain that has not responded to other treatments due to its ability to stimulate targeted nerves and muscles beneath the skin with minimal discomfort.

Clinical Context: Clinical research maintains there are two approaches to treating Neuropathy—one being high frequencies with sinusoidal alternating current with constant middle frequencies and the second being low therapeutically ranged frequencies.

• High Frequency with Middle Frequency attributes has been found in clinical and animal studies to enhance myelinated axon growth, accelerate nerve fiber maturation, and in some protocols, provide nerve conduction block for pain relief.
• Low Frequencies tends to promote endogenous opioid release and support regenerative cellular processes that aid in nerve regeneration.

Using proprietary settings—delivering a mix between high frequency and low frequency coupled with waveforms specific to treating one’s extremities—the NerveWave delivers therapeutic outcomes. These frequencies and waveforms have been found to stimulate both bioelectrical (low frequency) and biochemical (high frequency) processes in the body at the same time.

• Delivers gentle, non-fatiguing muscle contractions—primarily targeting small, slow-twitch muscle fibers and lymphatic movement within the muscle—accelerating the recovery process without causing additional strain or muscle fatigue.
• Increases vasodilation while boosting microcirculation and promoting angiogenesis in injured tissue, thus increasing healing.
• Low Frequency promotes lymphatic drainage, reduction of swelling and inflammation, and increasing healing within the muscle and tissue.
• High Frequency addresses post-surgical or post-injury pain syndromes by reducing reliance on pain medication, while increasing range of motion and strength during the rehab phase.

• Mild electrical impulses are delivered to the outer ear innervated by the auricular branch of the vagus nerve (ABVN), such as the tragus or cymba concha. This stimulation activates afferent nerve fibers that project to the brainstem, especially the nucleus tractus solitarius (NTS), and in turn modulate central autonomic activity, neurotransmitter release, and the balance of the sympathetic-parasympathetic nervous system.
• Parasympathetic Activation: taVNS increases parasympathetic outflow and reduces sympathetic activity, with clinical studies showing benefits ranging from reduced heart rate and inflammation to enhanced relaxation responses and improved autonomic balance, helping to regulate mood, control inflammation, and modulate involuntary bodily functions like heart rate and digestion.

By utilizing clinically studied electrotherapy specifications derived from advanced neurostimulation protocols, this treatment couples low-level frequencies with high-voltage, monophasic electrical currents. Delivered via a micro-probe directly to the meridian point, these precise waveforms bypass skin resistance to stimulate deep tissue and promote cellular repair. This targeted electrical field has been studied to stimulate chondrocyte activity, increase extracellular matrix production, and actively encourage cartilage regeneration within the joint capsule.

In addition to cellular repair, this therapy incorporates deep-penetrating currents that target chronic, intractable joint pain. The intersecting electrical paths penetrate deep into the dense connective tissues of the joint to block persistent pain signals, reduce chronic inflammation, and relax surrounding muscle spasms. This sub-dermal delivery mechanism ensures maximum therapeutic impact directly at the source of degeneration, providing profound relief for severe pain that has failed to respond to surface-level treatments.

By delivering a continuous, unidirectional flow of low-intensity electrical current, DC creates a sustained electrical field directly within damaged tissues. This constant polarity mimics the body’s natural injury currents, triggering a process called galvanotaxis which actively guides healing cells to the affected site. The DC flow increases cellular ATP production, accelerates protein synthesis, and stimulates the rapid repair of damaged ligaments, tendons, and muscles.

The steady directional current significantly enhances localized blood flow through targeted vasodilation, flushing out inflammatory waste products and delivering fresh oxygen and nutrients to the injury site. Because the current does not pulse, it penetrates deeply and smoothly, making it highly effective for chronic soft-tissue injuries that have resisted standard physical therapies.